Elevance Health Inc.ELVNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -92.60% |
| Q3 2025 | -44.74% |
| Q2 2025 | 101.97% |
| Q1 2025 | 44.05% |
| Q4 2024 | -73.63% |
| Q3 2024 | 498.88% |
| Q2 2024 | -77.40% |
| Q1 2024 | 166.58% |
| Q4 2023 | -213.70% |
| Q3 2023 | 34.00% |
| Q2 2023 | -69.86% |
| Q1 2023 | 526.15% |
| Q4 2022 | -130.83% |
| Q3 2022 | 100.82% |
| Q2 2022 | -3.50% |
| Q1 2022 | 51.97% |
| Q4 2021 | -33.23% |
| Q3 2021 | 48.78% |
| Q2 2021 | -32.81% |
| Q1 2021 | -34.30% |
| Q4 2020 | 431.57% |
| Q3 2020 | -120.87% |
| Q2 2020 | 119.09% |
| Q1 2020 | 89.53% |
| Q4 2019 | -20.40% |
| Q3 2019 | 16.01% |
| Q2 2019 | -11.84% |
| Q1 2019 | 252.05% |
| Q4 2018 | -23.71% |
| Q3 2018 | 11.93% |
| Q2 2018 | -75.52% |
| Q1 2018 | 270.22% |
| Q4 2017 | -154.11% |
| Q3 2017 | 511.73% |
| Q2 2017 | -85.38% |
| Q1 2017 | 878.59% |
| Q4 2016 | -71.49% |
| Q3 2016 | 45.54% |
| Q2 2016 | -49.24% |
| Q1 2016 | 37.42% |